Recently, the fog haze swept through half of China's large area, respiratory medicine market become hot. With the deterioration of air quality, the respiratory system disease prevalence is increasing in our country, the drug market is growing. Among them, the antitussive expectorant compound preparations become a hot market. According to kang CMH data, in 2015, the national retail pharmacies in the sale of antitussive expectorant compound preparations size of the total sales of 11.115 billion yuan. Taken together, antitussive expectorant compound preparations of market present situation and future opportunities?
Retail market size of ten billion
In recent years, with the worsening of air environment, people also gradually rise to the demand of respiratory disease medication, especially cough cold kind of medication, including cough expectorant compound preparations of many drug companies become the nuggets focus areas. In 2015, according to kang CMH data in respiratory medicine market size (in accordance with the terminal retail price calculation, similarly hereinafter) is 123.18 billion yuan, cough and cold medicines occupied 68.6% market share. Among them, the antitussive expectorant compound preparations in cough and cold medicines subdivision sub-types, antitussive expectorant compound preparations for 11.115 billion yuan of the size of the market become cough and cold medicines a great important class, its market potential.
Figure 1 2015 respiratory system drugs in the class of the market
Data sources: kang CMH
, according to kang CMH monitoring data of antitussive expectorant compound preparations in 2014 sales of 10.319 billion yuan, the growth rate of 3.76%; Sales of 11.115 billion yuan in 2015, the growth rate of 7.83%. The category of growth is still on the rise.
Data sources: kang CMH
Proprietary Chinese medicine
According to kang CMH monitoring data show that in the antitussive expectorant compound preparations of market structure of Chinese and western, proprietary Chinese medicine with a 93.83% market share and held a dominant position in sales of 10.43 billion yuan;; Compared with the national drug market proprietary Chinese medicine market share is only 25.2%. Can be found, proprietary Chinese medicine, with its symptoms, less side effects, no drug resistance of characteristics, in the field of respiratory medicine in our country.
In 2015, Chinese and western medicine retail market cough expectorant compound preparations market share
Data sources: kang CMH
In addition, it is worth mentioning, antitussive expectorant compound preparations of proprietary Chinese medicine because there are many different kinds of products, market concentration is low, the competition is fierce. One of the highest market share item - Kyoto read CiAn honey refined fritillary bulb become pipagao in, only 10.89% of market share, product market share after the TOP5. But cough, phlegm and asthma are the basic characteristics of the respiratory system disease, therefore, antitussive expectorant compound preparations also became a regular customize prevention products, consumer drug market growth potential in this field is very large.
2015 antitussive expectorant compound preparations need proprietary Chinese medicine best-selling products
Data sources: kang CMH
Potential brand analysis
In antitussive expectorant compound preparations of proprietary Chinese medicine competition heats up under the present situation, how to subdivide into, make the whole market cake become the key to break. From 2015 antitussive expectorant compound preparations proprietary Chinese medicine can be found in the top 10 best-selling products, product homogeneity is more severe.
Existing products, one of China's traditional Chinese medicine's fist products Chinese caterpillar fungus clearing lung capsule, cordyceps sinensis is a few on the market at present as antitussive expectorant compound agents well-known brands of raw materials. With the improvement of China's consumer health consciousness, to the side effects of proprietary Chinese medicines and raw material requirements will be increasingly improved. Caterpillar fungus clearing lung capsule is at the core of the user has a certain economic strength in the high-end consumer groups, with its high quality products, high quality materials, scientific ratio force, under the big health needs harvest double recognition of the industry and consumers. In recent years, the drug market sales data for years to grow, showed great market potential, the drug sales growth of 91.85% in 2014.
Another, Chinese caterpillar fungus clearing lung capsules will with large pharmacy chain pharmacies leading enterprise people reached a strategic cooperation in 2017, the drug will focus on the chain drug stores, for will become a Chinese herbal medicine OTC products to build the first key products, the two sides will in brand promotion, staffing, terminal three aspects of strong cooperation, believe that the drug market in 2017 will be further improved. |
